Troglitazone protects human erythrocytes from oxidant damage

Antioxidants and Redox Signaling

Volumn 2, Issue 2, 2000, Pages 243-250

  May, James M ^a   Qu, Zhi Chao ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; TROGLITAZONE;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG STRUCTURE; ERYTHROCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0033923369     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2000.2.2-243     Document Type: Article

References (30)

1. AMES, B.N. (1966). Assay of inorganic phosphate, total phosphate and phosphatases. Methods Enzymol. 8, 115-118.
2. BAYNES, J.W. (1991). Role of oxidative stress in development of complications-of diabetes. Diabetes 40, 405-412.
3. BIERI, J.G., EVARTS, R.P., and GART, J.J. (1976). Relative activity of alpha-tocopherol and gamma-tocopherol in preventing oxidative red cell hemolysis. J. Nutr. 106, 124-127.
4. COMINACINI, L., GARBIN, U., PASTORINO, A.M., FRATTA, P.A., CAMPAGNOLA, M., DE SANTIS, A., DAVOLI, A., and LO CASCIO, V. (1994). Increased susceptibility of LDL to in vitro oxidation in patients with insulin-dependent and non-insulin-dependent diabetes mellitus. Diabetes Res. 26, 173-184.
5. COMINACINI, L., GARBIN, U., PASTORINO, A.M., CAMPAGNOLA, M., PASINI, A.F., DAVOLI, A., RIGONI, A., and LO CASCIO, V. (1997a). Effects of troglitazone on in vitro oxidation of LDL and HDL induced by copper ions and endothelial cells. Diabetologia 40, 165-172.
6. COMINACINI, L., YOUNG, M.M., CAPRIATI, A., GARBIN, U., FRATTA, P.A., CAMPAGNOLA, M., DAVOLI, A., RIGONI, A., CONTESSI, G.B., and LO, C.V. (1997b). Troglitazone increases the resistance of low density lipoprotein to oxidation in healthy volunteers. Diabetologia 40, 1211-1218.
7. COMINACINI, L., GARBIN, U., PASINI, A.F., CAMPAGNOLA, M., DAVOLI, A., FOOT, E., SIGHIERI, G., SIRONI, A.M., LO, C., and FERRANNINI, E. (1998). Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration, in NIDDM patients. Diabetes 47, 130-133.
8. DIAZ, M.N., FREI, B., VITA, J.A., and KEANEY, J.F., JR. (1997). Mechanisms of disease - antioxidants and atherosclerotic heart disease. N. Engl. J. Med. 337, 408-416.
9. HORWTTT, M.K., HARVEY, C.C., and HARMON, E.M. (1968). Lipids, α-tocopherol and erythrocyte hemolysis. Vitamins Horm. 26, 487-499.
10. KOBAYASHI, T., ITABE, H., INOUE, K., and NOJIMA, S. (1985). Peroxidation of liposomes in the presence of human erythrocytes and induction of membrane damage of erythrocytes by peroxidized liposomes. Biochim. Biophys. Acta 814, 170-178.
11. LOI, C.-M., RANDINITIS, E.J., VASSOS, A.B., KAZIERAD, D.J., KOUP, J.R., and SEDMAN, A.J. (1997). Lack of effect of type II diabetes on the pharmacokinetics of troglitazone in a multiple-dose study. J. Clin. Pharmacol. 37, 1114-1120.
12. MAGGS, D.G., BUCHANAN, T.A., BURANT, C.F., CLINE, G., GUMBINER, B., HSUEH, W.A., INZUCCHI, S., KELLEY, D., NOLAN, J., OLEFSKY, J.M., POLONSKY, K.S., SILVER, D., VALIQUETT, T.R., and SHULMAN, G.I. (1998). Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 128, 176-185.
13. MAXWELL, S.R., and LIP, G.Y. (1997). Free radicals and antioxidants in cardiovascular disease. Br. J. Clin. Pharmacol. 44, 307-317.
14. MAY, J.M., QU, Z.-C., and MENDIRATTA, S. (1998). Protection and recycling of α-tocopherol in human erythrocytes by intracellular ascorbic acid. Arch. Biochem. Biophys. 349, 281-289.
15. MENDIRATTA, S., QU, Z.-C., and MAY, J.M. (1998). Erythrocyte ascorbate recycling: Antioxidant effects in blood. Free Radic. Biol. Med. 24, 789-797.
16. MILLER, Y.I., FELIKMAN, Y., and SHAKLAI, N. (1995). The involvement of low-density lipoprotein in hemin transport potentiates peroxidative damage. Biochim. Biophys. Acta 1272, 119-127.
17. MINO, M., NISHIDA, Y., MURATA, K., TAKEGAWA, M., KATSUI, G., and YUGUCHI, Y. (1978). Studies on the factors influencing the hydrogen peroxide hemolysis test; J. Nutr. Sci. Vitaminol. 24, 383-395.
18. NOGUCHI, N., SAKAI, H., KATO, Y., TSUCHIYA, J., YAMAMOTO, Y., NIKI, E., HORIKOSHI, H., and KODAMA, T. (1996). Inhibition of oxidation of low density lipoprotein by troglitazone. Atherosclerosis 123, 227-234.
19. NOUROOZ-ZADEH, J., TAJADDINI-SARMADI, J., and WOLFF, S.P. (1994). Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenyl-phosphine. Anal. Biochem. 220, 403-409.
20. ORRINGER, E.P., and ROER, M.E. (1979). An ascorbate-mediated transmembrane-reducing system of the human erythrocyte. J. Clin. Invest. 63, 53-58.
21. SALTIEL, A.R., and OLEFSKY, J.M. (1996). Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45, 1661-1669.
22. SCHWARTZ, S., RASKIN, P., FONSECA, V., and GRAVELINE, J.F. (1998). Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group. N. Engl. J. Med. 338, 861-866.
23. SHIBUKAWA, A., SAWADA, T., NAKAO, C., IZUMI, T., and NAKAGAWA, T. (1995). High-performance frontal analysis for the study of protein binding of troglitazone (CS-(MS) in albumin solution and in human plasma. J. Chromatogr. A 697, 337-343.
24. SPIEGELMAN, B.M. (1998). PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor. Diabetes 47, 507-514.
25. STECK, T.L., and KANT, J.A. (1974). Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. Methods Enzymol. 31, 172-180.
26. TACK, C.J., SMITS, P., DEMACKER, P.N., and STALENHOEF, A.F. (1998). Troglitazone decreases the proportion of small, dense LDL and increases the resistance of LDL to oxidation in obese subjects. Diabetes Care 21, 796-799.
27. TAKEDA, H., SHIBUYA, T., YANAGAWA, K., KANOH, H., and TAKASAKI, M. (1996). Simultaneous determination of α-tocopherol and α-tocopherolquinone by high-performance liquid chromatography and coulometric detection in the redox mode. J. Chromatogr. A 722, 287-294.
28. WATERS, R.E., WHITE, L.L., and MAY, J.M. (1997). Liposomes containing alpha-tocopherol and ascorbate are protected from an external oxidant stress. Free Radic. Res. 26, 373-379.
29. WOLFF, S.P. (1994). Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Methods Enzymol. 233, 182-189.
30. YOSHIOKA, T., FUJITA, T., KANAI, T., AIZAWA, Y., KURUMADA, T., HASEGAWA, K., and HORIKOSHI, H. (1989). Studies on hindered phenols and analogues. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation. J. Med. Chem. 32, 421-128.